Skip to main content
CRBP filings

Corporate insider profile

Yuval Cohen Filing Activity

Latest reported as Chief Executive Officer of Corbus Pharmaceuticals Holdings, Inc. (CRBP).

Purchase filings
0
Reported companies
1
Net open-market value
-$171,395.70
Latest transaction
Aug 7, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 7, 2026Corbus Pharmaceuticals Holdings, Inc. (CRBP)Chief Executive OfficerSale17,000$10.08$171,396